Secondary Raynaud's Disease
Showing 1 - 25 of >10,000
Raynaud Phenomenon Secondary to Systemic Sclerosis Trial in Paris (BOTOX® solution, Placebo group)
Completed
- Raynaud Phenomenon Secondary to Systemic Sclerosis
- BOTOX® solution
- Placebo group
-
Paris, FranceHôpital Tenon
Feb 9, 2022
Raynaud's Phenomenon Trial in Boston (oral treprostinil, Placebo)
Completed
- Raynaud's Phenomenon
- oral treprostinil
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 5, 2022
Metabolomic Analysis of Systemic Sclerosis
Recruiting
- Scleroderma (Limited and Diffuse)
- +4 more
- - Skin biopsy - Urine sample - Blood sample
-
Dijon, France
- +3 more
Jul 7, 2022
Buerger Disease, Raynaud Syndrome Trial (BOTOX INJECTION)
Not yet recruiting
- Buerger Disease
- Raynaud Syndrome
- BOTOX INJECTION
- (no location specified)
Jan 16, 2023
Raynaud Disease, Raynaud Phenomenon, Raynaud Syndrome Trial in Minneapolis (Blue Light Therapy, Sham Light Therapy)
Not yet recruiting
- Raynaud Disease
- +2 more
- Blue Light Therapy
- Sham Light Therapy
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 17, 2022
Systemic Sclerosis, Fatigue, Raynaud Phenomenon Trial in Pittsburgh (Apollo)
Active, not recruiting
- Systemic Sclerosis
- +2 more
- Apollo
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh School of Medicine
Jan 4, 2023
Raynaud's Phenomenon Secondary to Systemic Sclerosis Trial in United States (Placebo IV infusion, Iloprost Injection, for
Completed
- Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Placebo IV infusion
- Iloprost Injection, for intravenous use
-
Phoenix, Arizona
- +29 more
Jul 13, 2021
Raynaud's Phenomenon Isolated Primary, Raynaud's Phenomenon (Secondary), Healthy Trial in Grenoble (Biopsy)
Completed
- Raynaud's Phenomenon Isolated Primary
- +2 more
- Biopsy
-
Grenoble, Isère, FranceCHU of Grenoble Alpes
Apr 8, 2020
Raynaud Phenomenon Trial in Atlanta (Botulinum toxin)
Recruiting
- Raynaud Phenomenon
- Botulinum toxin
-
Atlanta, GeorgiaEmory University Hospital
Feb 10, 2022
Dermoscopy in Primary Raynaud's Phenomenon
Completed
- Raynaud Phenomenon
- Dermoscopy
-
Paris, FranceHôpital de Tenon
Jul 19, 2021
Screening and Secondary Prevention Rheumatic Heart Disease Study
Recruiting
- Rheumatic Heart Disease
-
Karachi, Sindh, PakistanNational Institute of Cardiovascular Diseases (NICVD)
Aug 12, 2023
Primary Raynaud Phenomenon Trial in Nottingham (High Flavanol Cocoa extract, Alkalised cocoa)
Completed
- Primary Raynaud Phenomenon
- High Flavanol Cocoa extract
- Alkalised cocoa
-
Nottingham, Notts, United KingdomDavid Greenfield Human Physiology Laboratories
Nov 3, 2021
Efficacy and Safety of Pacitol Inj.
Recruiting
- Chronic Kidney Disease 5D
- Secondary Hyperparathyroidism
-
Goyang-si, Gyeonggi-do, Korea, Republic ofDongGuk university Ilsan hospital
Nov 6, 2023
Parkinson Disease, Physical Therapy Modalities, Frailty Trial in Oviedo (Home Physiotherapy Group, Control Group)
Enrolling by invitation
- Parkinson Disease
- +2 more
- Home Physiotherapy Group
- Control Group
-
Oviedo, SpainUniversity of Oviedo
Nov 7, 2022
Raynaud Phenomenon Trial in Orlando (AbobotulinumtoxinA, Saline solution)
Terminated
- Raynaud Phenomenon
- AbobotulinumtoxinA
- Saline solution
-
Orlando, FloridaUCF Health Lake Nona Office
Jun 9, 2021
Rheumatic Heart Disease Trial in Kampala (Primary Training Phase, Primary Assessment Phase, Primary Screening Phase)
Active, not recruiting
- Rheumatic Heart Disease
- Primary Training Phase
- +5 more
-
Kampala, UgandaUganda Heart Institute
Jan 27, 2023
Secondary Hyperparathyroidism, End Stage Kidney Disease Trial (PLS240, Placebo, Open-Label Extension PLS240)
Not yet recruiting
- Secondary Hyperparathyroidism
- End Stage Kidney Disease
- PLS240
- +2 more
- (no location specified)
Apr 18, 2023
Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Vitamin d Deficiency Trial (CTAP101, Placebo)
Not yet recruiting
- Chronic Kidney Disease stage3
- +3 more
- CTAP101
- Placebo
- (no location specified)
Sep 13, 2022
Raynaud Phenomenon Trial in Grenoble (L-citrulline, Beetroot juice, L-citrulline )
Recruiting
- Raynaud Phenomenon
- L-citrulline
- +3 more
-
Grenoble, FranceGrenoble University Hospital
May 12, 2021
Secondary Hyperparathyroidism Trial (PLS240, Placebo, Open-Label Extension PLS240)
Not yet recruiting
- Secondary Hyperparathyroidism
- PLS240
- +2 more
- (no location specified)
Apr 17, 2023
3T MR for Secondary Hyperparathyroidism Comparison With 4DCT
Not yet recruiting
- Parathyroid Gland Disease
- Secondary Hyperparathyroidism
- (no location specified)
Sep 15, 2022
Cytomegalovirus Infections, Infection in Solid Organ Transplant Recipients, Neutropenia Trial (Letermovir)
Not yet recruiting
- Cytomegalovirus Infections
- +3 more
- (no location specified)
Jan 17, 2023
Rheumatic Heart Disease, Rheumatic Heart Disease in Children Trial in Tulsipur (School nurse program)
Recruiting
- Rheumatic Heart Disease
- Rheumatic Heart Disease in Children
- School nurse program
-
Tulsipur, NepalTulsi Secondary Boarding School
Aug 15, 2022
Coronary Artery Disease Trial in Hasselt (Smartphone application)
Completed
- Coronary Artery Disease
- Smartphone application
-
Hasselt, Limburg, BelgiumJessa Hospital
Sep 5, 2022